| 104280-3 | ABCG2 gene.p.Q141K or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH.MUT |
| 104281-1 | ABCB1 gene.c.1236C>T or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH.MUT |
| 104282-9 | ABCB1 gene.c.2677G>T or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH.MUT |
| 104283-7 | DPYD gene.c.2846A>T or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH.MUT |
| 104284-5 | DPYD gene.c.1679T>G or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH.MUT |
| 104285-2 | UGT1A1 gene.p.G71R or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH.MUT |
| 104286-0 | UGT1A1 gene.p.P229Q or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH.MUT |
| 104287-8 | SLCO1B1 gene.c.521T>C or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH.MUT |
| 104288-6 | HLA-B gene.g.31431780T>G or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH.MUT |
| 104289-4 | Chromosome 5 and 9 and 15 aneuploidy (Bone Marrow, fish) | MOLPATH |
| 10429-9 | AE 1 Ag (Tissue, qualitative, immune stain) | CELLMARK |
| 104290-2 | ROS proto-oncogene 1 mutations tested for or Tissue (Blood, molecular genetics method nominal) | MOLPATH.MUT |
| 104291-0 | KIT gene mutations tested for or Tissue (Blood, molecular genetics method nominal) | MOLPATH |
| 104292-8 | PDGFRA gene mutations tested for or Tissue (Blood, molecular genetics method nominal) | MOLPATH |
| 104293-6 | PDGFRA gene mutations found or Tissue (Blood, molecular genetics method nominal) | MOLPATH.MUT |
| 104294-4 | CDH1 gene rearrangements or Tissue (Blood, molecular genetics method narrative) | MOLPATH.REARRANGE |
| 104295-1 | ESR1 gene mutation or Tissue (Blood, molecular genetics method nominal) | MOLPATH |
| 104296-9 | DPYD gene.c.1905+1G>A or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH |
| 104297-7 | CYP3A4 gene c.6C>T or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH.PHARMG |
| 104298-5 | CYP3A4 gene.c.IVS10+12G>A or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH.PHARMG |
| 104299-3 | UGT1A9 gene.1b-118(dT)9>10 or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH.TRNLOC |
| 1043-9 | H Ab from Donor (qualitative) | BLDBK |
| 10430-7 | AE 3 Ag (Tissue, qualitative, immune stain) | CELLMARK |
| 104300-9 | UGT1A9 gene.p.M33T or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH |
| 104301-7 | UGT1A9 gene.c.-2152C>T or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH |
| 104302-5 | UGT1A9 gene.c.-275T>A or Tissue (Blood, qualitative, molecular genetics method) | MOLPATH.MUT |
| 104303-3 | N-Desmethyl imatinib | DRUG/TOX |
| 104304-1 | Regorafenib | DRUG/TOX |
| 104305-8 | Regorafenib N-oxide | DRUG/TOX |
| 104306-6 | Sorafenib N-Oxide | DRUG/TOX |
| 104307-4 | Letrozole | DRUG/TOX |
| 104308-2 | Palbociclib | DRUG/TOX |
| 104309-0 | Ribociclib | DRUG/TOX |
| 10431-5 | B-cell Ag (Tissue, qualitative, immune stain) | CELLMARK |
| 104310-8 | Abemaciclib | DRUG/TOX |
| 104311-6 | Olaparib | DRUG/TOX |
| 104312-4 | Rucaparib | DRUG/TOX |
| 104313-2 | Niraparib | DRUG/TOX |
| 104314-0 | Lenvatinib | DRUG/TOX |
| 104315-7 | Sunitinib | DRUG/TOX |
| 104316-5 | N-Desethyl Sunitinib | DRUG/TOX |
| 104317-3 | Common myeloid progenitor cell (Blood, visual count) | CELLMARK |
| 104318-1 | Common myeloid progenitor cell (Blood) | CELLMARK |
| 104319-9 | Burst forming unit erythroid (Blood, visual count) | CELLMARK |
| 10432-3 | CD30 Ag (Tissue, qualitative, immune stain) | CELLMARK |
| 104320-7 | Burst forming unit erythroid (Blood) | DRUG/TOX |
| 104321-5 | CXCR4 gene mutations found or Tissue (Blood, molecular genetics method nominal) | MOLPATH |
| 104322-3 | Lambda lymphocytes/Lymphocytes (Bone Marrow) | CELLMARK |
| 104323-1 | IDH1 and IDH2 gene full mutation analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 104324-9 | Acinetobacter sp identified in Specimen (sequencing) | MICRO |